| Literature DB >> 30604928 |
Elias Polykandriotis1,2, Raymund E Horch2, Matthias Jost3, Andreas Arkudas2, Frieder Kees4, Marweh Schmitz2.
Abstract
In this study, we evaluated a new aspect of negative pressure wound therapy (NPWT) as an analytical tool for pharmacokinetic studies. Twenty-one patients with soft tissue defects scheduled to receive NPWT were included in this study. Concomitant to NPWT, all patients received intravenous moxifloxacin (MX). At different time intervals, blood plasma levels of MX were sampled and compared with synchronous concentrations of MX in the exudate obtained from the NPWT drainage system. Serial measurements were performed upon initiation of the therapy as well as in the steady state (after 5 days). At steady state, wound tissue was obtained intraoperatively. High-performance liquid-chromatography (HPLC) was used for analysis. At 1 hour post-administration, the exudate/plasma levels (mg/L) were 1.92/3.07; at 12 hours, 0.80/1.14; at 24 hours, 0.26/0.43; and at 120 hours (steady state), 0.42/0.47. There was a correlation between exudate and plasma levels reaching approximately 0.75. Until now, methods for pharmacokinetic studies concerning interstitial fluid are difficult to apply in the clinical context. The presented method showed limitations, but we believe that, after methodological improvements, measurements of substances in the interstitial fluid by means of NPWT are feasible.Entities:
Keywords: interstitial fluid; moxifloxacin; negative pressure wound therapy (NPWT); pharmacokinetics; wound infection
Mesh:
Substances:
Year: 2019 PMID: 30604928 PMCID: PMC7948631 DOI: 10.1111/iwj.13063
Source DB: PubMed Journal: Int Wound J ISSN: 1742-4801 Impact factor: 3.315